Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("cardiovascular drugs")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 32

  • Page / 2
Export

Selection :

  • and

A Pharmaceutical Care Program to Improve Adherence to Statin Therapy: A Randomized Controlled TrialEUSSEN, Simone R. B. M; VAN DER ELST, Menno E; KLUNGEL, Olaf H et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 12, pp 1905-1913, issn 1060-0280, 9 p.Article

Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular functionREIKVAM, Aasmund; KVAN, Elena; LANDMARK, Knud et al.SCJ. Scandinavian cardiovascular journal. 2003, Vol 37, Num 3, pp 130-134, issn 1401-7431, 5 p.Article

Ageing with HIV: medication use and risk for potential drug-drug interactionsMARZOLINI, Catia; BACK, David; ELZI, Luigia et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 9, pp 2107-2111, issn 0305-7453, 5 p.Article

Pharmacodynamic Hybrids Coupling Established Cardiovascular Mechanisms of Action with Additional Nitric Oxide Releasing PropertiesMARTELLI, Alma; BRESCHI, Maria Cristina; CALDERONE, Vincenzo et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 6, pp 614-636, issn 1381-6128, 23 p.Article

Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based studyLAURSEN, T. M; MORTENSEN, P. B; MACCABE, J. H et al.Psychological medicine (Print). 2014, Vol 44, Num 8, pp 1625-1637, issn 0033-2917, 13 p.Article

Pharmacogenomics in cardiovascular medicineCARLQUIST, John F; ANDERSON, Jeffrey L.Drug development research. 2004, Vol 62, Num 3, pp 180-190, issn 0272-4391, 11 p.Article

Beneficiaries With Cardiovascular Disease and the Part D Coverage GapPOLINSKI, Jennifer M; SHRANK, William H; GLYNN, Robert J et al.Circulation. Cardiovascular quality and outcomes (Print). 2012, Vol 5, Num 3, pp 387-395, issn 1941-7713, 9 p.Article

Baseline and Follow-up Laboratory Monitoring of Cardiovascular MedicationsTJIA, Jennifer; FISCHER, Shira H; RAEBEL, Marsha A et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 9, pp 1077-1084, issn 1060-0280, 8 p.Article

Psoriasis May Not Be an Independent Predictor for the Use of Cardiovascular and Anti-diabetic Drugs: A 5-year Prevalence StudyWAKKEE, Marlies; MEIJER, Willemijn; MARTINO NEUMANN, H. A et al.Acta dermato-venereologica. 2009, Vol 89, Num 5, pp 476-483, issn 0001-5555, 8 p.Article

Long-term continuation on cardiovascular drug treatment in patients with coronary heart diseaseWALD, David S; MORTON, Geraint; WALKER, Kate et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 10, pp 1644-1647, issn 1060-0280, 4 p.Article

Use of cardiovascular drugs after acute myocardial infarction: A marked shift towards evidence-based drug therapyREIKVAM, Asmund; KVAN, Elena; AURSNES, Ivar et al.Cardiovascular drugs and therapy. 2002, Vol 16, Num 5, pp 451-456, issn 0920-3206, 6 p.Article

Paediatric formulations- : Getting to the heart of the problemSTANDING, Joseph F; TULEU, Catherine.International journal of pharmaceutics. 2005, Vol 300, Num 1-2, pp 56-66, issn 0378-5173, 11 p.Article

Cardiovascular drugs and the risk of suicide : a nested case-control studyCALLREUS, Torbjörn; ANDERSEN, Ulla Agerskov; HALLAS, Jesper et al.European journal of clinical pharmacology. 2007, Vol 63, Num 6, pp 591-596, issn 0031-6970, 6 p.Article

The association between use of cardiovascular drugs and antidepressants : a nationwide register-based studyJOHNELL, Kristina; FASTBOM, Johan.European journal of clinical pharmacology. 2008, Vol 64, Num 11, pp 1119-1124, issn 0031-6970, 6 p.Article

Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensivesNILSSON, J. Lars G; LINDBERG, Gunnar; JOHANSSON, Hans et al.European journal of clinical pharmacology. 2006, Vol 62, Num 8, pp 675-680, issn 0031-6970, 6 p.Article

Efficacy, safety and cost of new cardiovascular drugs: a surveyGARATTINI, Silvio; BERTELE, Vittorio.European journal of clinical pharmacology. 2003, Vol 59, Num 8-9, pp 701-706, issn 0031-6970, 6 p.Article

Connecting pre-marketing clinical research and medical practice opinion-based study of core issues and possible changes in drug regulationWIERINGA, Nicolien F; PESCHAR, Jules L; DENIG, Petra et al.International journal of technology assessment in health care. 2003, Vol 19, Num 1, pp 202-219, issn 0266-4623, 18 p.Article

Clinical and economic outcomes of a fall-focused pharmaceutical intervention programHAUMSCHILD, Mark J; KARFONTA, Terry L; HAUMSCHILD, Mary S et al.American journal of health-system pharmacy. 2003, Vol 60, Num 10, pp 1029-1032, issn 1079-2082, 4 p.Conference Paper

Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the futureMAZUMDAR, K; ASOK KUMAR, K; DUTTA, N. K et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 4, pp 295-302, issn 0924-8579, 8 p.Article

Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapyGONZALEZ, Oskar; ALONSO, Rosa Maria; FERREIROS, Nerea et al.Journal of chromatography. B. 2011, Vol 879, Num 3-4, pp 243-252, issn 1570-0232, 10 p.Article

Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissionsRODENBURG, Eline M; STRICKER, Bruno H; VISSER, Loes E et al.British journal of clinical pharmacology. 2012, Vol 74, Num 6, pp 1045-1052, issn 0306-5251, 8 p.Article

Engineering Therapeutic Nanocarriers with Optimal Adhesion for TargetingHAUN, Jered B; ROBBINS, Gregory P; HAMMER, Daniel A et al.The Journal of adhesion (Print). 2010, Vol 86, Num 1-3, pp 131-159, issn 0021-8464, 29 p.Article

Nature of preventable adverse drug events in hospitals: A literature reviewKANJANARAT, Penkarn; WINTERSTEIN, Almut G; JOHNS, Thomas E et al.American journal of health-system pharmacy. 2003, Vol 60, Num 17, pp 1750-1759, issn 1079-2082, 10 p.Conference Paper

The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very oldKLARIN, Inga; FASTBOM, Johan; WIMO, Anders et al.European journal of clinical pharmacology. 2006, Vol 62, Num 7, pp 555-562, issn 0031-6970, 8 p.Article

Patterns of cardiovascular drugs prescribed for an elderly Swedish populationMOZHU DING; RUI WANG; JOHNELL, Kristina et al.International journal of cardiology. 2014, Vol 177, Num 3, pp 1091-1094, issn 0167-5273, 4 p.Article

  • Page / 2